This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Clinical features

Authoring team

A common presenting symptom is the so-called 'hand and foot syndrome' which occurs in early infancy and is characterised by painful dactylitis. Later in life the bone pain is widespread and particularly marked in the back and limbs. The pain is frequently bilateral and symmetrical; it tends to be close to joints and can be mistaken for pauciarticular arthritis.

Acute painful episodes are characterised into 4 distinct phases:

  • prodromal phase (pre-crisis):
    • patients feel numbness, aches and paresthesia in the sites which will be affected by pain
    • can last for two days
  • initial infarctive phase:
    • characterised by the onset of typical crisis pain
    • the pain increases gradually with a peak around the second or third day
    • infarction from sickling of red blood cells was thought to be responsible for the pain episodes although newer evidence suggest a much more complicated pathophysilogy
  • post-infarctive phase:
    • there is persistent severe pain
    • signs and symptoms of inflammation are seen mostly
  • resolving (post-crisis) phase:
    • pain slowly resolves over one to two days (1)

Reference:


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.